➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Atrasentan

Email this page to a colleague

« Back to Dashboard

What is the drug development status for Atrasentan?

Atrasentan is an investigational drug.

There have been 19 clinical trials for Atrasentan. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2001.

The most common disease conditions in clinical trials are Kidney Diseases, Prostatic Neoplasms, and Diabetic Nephropathies. The leading clinical trial sponsors are Abbott, National Cancer Institute (NCI), and AbbVie (prior sponsor, Abbott).

Recent Clinical Trials for Atrasentan
Atrasentan in Patients With Proteinuric Glomerular DiseasesChinook Therapeutics U.S., Inc.Phase 2
Atrasentan in Patients With IgA NephropathyChinook Therapeutics U.S., Inc.Phase 3
Atrasentan Spermatogenesis and Testicular FunctionAbbViePhase 2

See all Atrasentan clinical trials

Clinical Trial Summary for Atrasentan

Top disease conditions for Atrasentan
Top clinical trial sponsors for Atrasentan

See all Atrasentan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.